Lung Cancer Clinical Trial
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
Summary
This research study is designed to develop and test a new supportive care program to help individuals with lung cancer improve their quality of life after cancer treatment is over.
Full Description
The aims of this pilot study are to evaluate the feasibility and acceptability of a brief psychoeducational intervention for participants with cancer who are transitioning from active treatment to surveillance.
The research study procedures include screening for eligibility.
This study consists of 2 parts. It is expected that about 45 people will take part in this research study.
In the first part of this study, about 5 participants will complete survey questions and receive a 5-session program.
In the second part of this study, about 40 participants will complete 3 surveys, and then will be randomly assigned to receive the 5-session program or to receive one study session (control).
These sessions will focus on providing targeted support related to life after cancer treatment. The sessions will focus on skills for coping with uncertainty, managing symptoms, improving social support, and other topics important to the individual.
Eligibility Criteria
Inclusion Criteria:
Age 21 or older
Diagnosis of non-small cell (NSCLC) or small cell (SCLC) lung cancer or mesothelioma
Documented treatment plan with curative intent
Ability to read and respond in English
Treatment completion eligibility:
Run-in: Has completed treatment including systemic treatments and radiation as determined within the past three weeks by the cancer care team at Massachusetts General Hospital.
RCT: Has completed treatment including systemic treatments +/- radiation and +/- surgery.
If final treatment is systemic therapy +/- radiation: within three weeks after cancer care team determination that treatment is complete.
If final treatment is surgery: within three weeks after hospital discharge following surgery.
Exclusion Criteria:
Comorbid health condition that would interfere with study participation
Current participation in cognitive behavioral therapy treatment
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02115, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.